C
Cohance Lifesciences
COHANCE Share Price
Healthcare296.10
as on 13 Mar 2026 at 15:45
Market Cap
₹11,328 Cr
PE Ratio
42.80
ROCE
13.36%
COHANCE Fundamentals
Company Valuation
Market Cap (₹ Cr.)
11,328
PE Ratio
42.80
PB Ratio
2.93
Dividend Yield
-
ROE
14.38%
ROCE
13.36%
Book Value (₹)
99.01
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Mar 2025 | May 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 50.10% | 66.41% | 66.41% | 57.49% | 57.49% |
| Domestic Institutional Investors (DII) | 16.60% | 11.02% | 11.40% | 20.82% | 21.57% |
| Foreign Institutional Investors (FII) | 11.05% | 7.38% | 7.23% | 6.51% | 6.02% |
| Public Investors | 9.68% | 6.63% | 6.40% | 6.42% | 6.76% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
COHANCE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
543064
NSE Scrip Name
COHANCE
ISIN
INE03QK01018



